www.imagingeconomics.com/issues/articles/2008-10_15.asp -
[Cached Version]
Published on: 10/1/2008
Last Visited: 1/16/2009
"In general, I am an early adopter for new advances in breast technologies, and as we move forward here we may find a role for BSGI in addition to—or instead of—breast MRI," said Pat Whitworth, MD, director, Nashville Breast Center, and immediate past chairman of the board and chairman of the research committee of the American Society of Breast Surgeons.
High-risk patients with dense breast tissue are benefiting from BSGI.
But presently, Whitworth is still waiting.
Why?
Whitworth thinks good things are worth the wait.
"I am intrigued because two or three studies say BSGI is as sensitive as breast MRI," Whitworth said.
He admits he is not an expert on the subject, and that is one reason he is not utilizing the technology in his practice.
...
BSGI is less expensive overall, more comfortable for the patient, and according to studies, it's as sensitive and as specific as breast MRI," Whitworth said.
"But for the medical community, that's hard to believe.
It's like moving a giant tanker ship and getting it to turn."
Says Whitworth, it will simply take time and more data.